Protagenic Therapeutics, Inc.\new Cash
Protagenic Therapeutics, Inc.\new (PTIX) had Cash of $565.99 thousand as of 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:Cash · last filed 2026-08-19
- 2026-06-30: Cash $565.99K.
- 2026-03-31: Cash $1.51M.
- 2025-12-31: Cash $2.21M.
- 2025-09-30: Cash $2.72M.
| Period end | Cash | Cash as first filed |
|---|---|---|
| 2026-06-30 | $565.99K 10-Q · filed 2026-08-19 | |
| 2026-03-31 | $1.51M 10-Q · filed 2026-08-19 | |
| 2025-12-31 | $2.21M 10-Q · filed 2026-03-09 | |
| 2025-09-30 | $2.72M 10-Q · filed 2025-11-26 | |
| 2025-06-30 | $4.10M 10-QT · filed 2025-09-10 | |
| 2025-03-31 | $14.53K 10-K · filed 2026-08-14 | $872.96K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $1.84M 10-Q · filed 2025-05-13 | |
| 2024-09-30 | $1.06M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $924.60K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $831.78K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $1.29M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $153.33K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $219.44K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $138.49K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $215.19K 10-K/A · filed 2024-05-14 | |
| 2022-09-30 | $158.32K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $338.67K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $482.18K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $541.17K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $460.12K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $11.93M 10-Q · filed 2021-08-16 | |
| 2020-12-31 | $671.09K 10-K · filed 2022-04-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |